Streetbeat News

Products Services

FRGT

Freight Technologies has received a Request For Quotation (RFQ) from an undisclosed pharmaceutical company. Under the RFQ, Fr8App, a product of Freight Technologies, has been awarded 33 lanes to transport pharmaceutical goods from the United States to Mexico and Canada.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2023 | 10:34 am

BEAM

Beam Therapeutics has presented preclinical data that highlights the utility and durability of BEAM-301 in correcting a mutation causing Glycogen Storage Disease Type I. The data was presented at the ESGCT.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2023 | 10:33 am

AMZN

Amazon Web Services (AWS), a unit of Amazon.com, Inc., plans to launch the AWS European Sovereign Cloud, a new, independent cloud for Europe designed to help public sector customers and those in highly regulated industries meet stringent regulatory data residency and operational requirements. The cloud will allow customers to keep all metadata they create within the European Union (EU). The AWS European Sovereign Cloud will be physically and logically separate from existing AWS Regions and will launch with its first AWS Region in Germany.

Portfolio Pulse from Nabaparna Bhattacharya

October 25, 2023 | 10:28 am

JKS

JinkoSolar has signed a supply agreement to provide 3.8 GW N-Type Tiger Neo modules for ACWA Power's two projects in Saudi Arabia. The terms of the agreement were not disclosed.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2023 | 10:22 am

AAPL

Apple Inc.'s iPhone 15 Pro has received the lowest 5-star rating since the iPhone 8, according to an analysis of 695,000 customer reviews. Only 72% of buyers rated the iPhone 15 Pro five stars in the first month since its launch. This is a 12% drop compared to the iPhone 13 Pro. The iPhone 15 Pro series has faced multiple issues like overheating, paint chipping, and display burn-in, which could have contributed to the negative perception.

Portfolio Pulse from Rounak Jain

October 25, 2023 | 10:09 am

GBX

Greenbrier Companies Inc. (GBX) expects to deliver between 22,500 and 25,000 units in FY24, including approximately 1,000 units in Brazil. The company anticipates revenue of $3.4 billion to $3.7 billion.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2023 | 10:08 am

BC

Brunswick Corporation (BC) is launching Brunswick Finance, a new private label, digital retail financing solution. The platform, set to launch before the end of the year, will offer end-to-end integration across the boat buying ecosystem, from pre-qualification to underwriting, finalizing agreements, and e-signing for loans.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2023 | 10:06 am

TSLA

Tesla's Model Y has broken a decade-long sales record in Denmark, surpassing the total annual sales of all other vehicles. The Model Y, launched in Denmark in the second half of 2021, has consistently topped the monthly sales charts throughout 2023. As of October, Tesla has sold more Model Ys in Denmark this year than any other vehicle in the country's history. This milestone reflects the global success of the Model Y, which passed the 2 million sales mark earlier this month and is poised to outsell the Model 3 as the best-selling electric vehicle.

Portfolio Pulse from Benzinga Neuro

October 25, 2023 | 10:05 am

MMTOF

NSANY

The top-selling electric vehicle (EV) in Japan is the Sakura, a kei car co-developed by Nissan Motor Co. (OTC:NSANY) and Mitsubishi Motors Corp. (OTC:MMTOF). The Sakura and its Mitsubishi counterpart, the eK X, account for nearly half of all EV sales in Japan this year. Despite the overall subdued EV market in Japan, these models have found favor with consumers for their affordability and practicality. However, success in Japan doesn’t translate into overseas sales due to stricter collision standards and regulations in other countries.

Portfolio Pulse from Benzinga Neuro

October 25, 2023 | 9:36 am

BIVI

BioVie is set to present blinded data on NE3107, a treatment for mild to moderate Alzheimer's disease, at the Clinical Trials on Alzheimer's Disease (CTAD) conference. The company's shares are up 31% in premarket trading.

Portfolio Pulse from Charles Gross

October 25, 2023 | 9:25 am